Clinical Trial Update: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of the oncolytic herpes simplex virus HSV-1716 in children with refractory or recurrent high-grade glioma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Giant Cell Glioblastoma
• Glioblastoma
• Gliomatosis Cerebri
• Gliosarcoma

Drugs mentioned

• Oncolytic HSV-1716 (Herpes simplex virus-1 HSV-1716)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma | Phase 1 | Status: TERMINATED